AKAN: Akanda Corporation P/S Multiple

Symbol and logo of brand Akanda Corp (AKAN)

Akanda is overcoming a prolonged downturn in the European medical cannabis sector through asset optimization. This P/S chart visualizes this stage, where the metric stands at 2.70. AI-driven greenhouse automation is driving efficiency gains, while a global presence across Africa and Europe minimizes regional risks. The multiplier's dynamics help determine the entry point into the asset.

AKAN (Akanda Corp) P/S Multiple history from 04/28/2023 to 11/13/2026

Analytical breakdowns for Akanda Corporation (AKAN)

- stock value and consensus price forecast:
Stock Price akandacorp.com|AKAN - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Akanda Corporation|AKAN - Total Company Value
- balance sheet equity data:
Equity per Share Akanda|AKAN - Book Capitalization|Capitalization to Book Value Ratio akandacorp.com|AKAN - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Akanda|AKAN - Long-Term Debt to Capital|Short-Term Debt to Capital Akanda Inc|AKAN - Company Debts|Debts to Book Capitalization Akanda Corporation|AKAN - Company Long-Term Debts|Company Short-Term Debts Akanda|Immediate Liquidity Ratio akandacorp.com
- net income and valuation multiples indicators:
AKAN - Company Net Income|Net Profit Forecast Akanda|AKAN - P/E Multiple|Forward P/E Multiple Akanda Corp|AKAN - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Akanda Corporation|AKAN - Operating profit EBITDA|Net earnings per share for the last 12 months Akanda|AKAN - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months akandacorp.com|AKAN - Net earnings per share growth this year|Expected earnings per share trend next year Akanda
- issuer revenue and sales details:
AKAN - Revenue and Sales Volume|Company Expected Revenue akandacorp.com|AKAN - P/S Multiple|Forward P/S Multiple Akanda Corporation
Fundamental company analysis:AKAN akandacorp.com
Signature product of Akanda Corporation

The selection of high-quality issuers is based on comparing market capitalization with actual sales volumes, which allows for the identification of undervalued assets. This multiple measures the cost per unit of revenue to help determine if a stock is overbought, while the fact that Akanda (AKAN) operates exclusively within the US domestic market minimizes external risks, making the historical P/S a reliable tool for assessing the business's fundamental stability.

Competing companies

P/S Multiple indivior.com (INDV)|P/S Multiple COLL (Collegium Pharmaceutical, Inc.)|P/S Multiple Cronos Group Inc CRON|CGC - Price-to-Revenue Ratio|HITI (Canna Cabana) - Market Cap to Revenue Ratio|ACB: P/S Multiple|Market Cap to Revenue Ratio ACHV|SKYE (Skye Bioscience) - P/S Multiple|P/S Multiple Anebulo Pharmaceuticals Inc|P/S Multiple INCR|P/S Multiple nutriband.com (NTRB)|Price-to-Revenue Ratio Nasus Pharma NSRX|P/S Multiple India Globalization Capital IGC|MIRA Pharma - P/S Multiple|FLGC - P/S Multiple|imcannabis.com (IMCC) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio ADIL|Price-to-Revenue Ratio Artelo Biosciences Inc.|Market Cap to Revenue Ratio ENSC (Ensysce)|P/S Multiple TTNP|P/S Multiple Greenlane Holdings, Inc. (GNLN)|Price-to-Revenue Ratio InMed Pharma INM|Market Capitalization-to-Revenue Ratio ENVB|Bright Green Corp - P/S Multiple|Hempacco Co Inc. (HPCO) - Market Cap to Revenue